WO2005004842A3 - Formulations for coated microprojections containing non-volatile counterions - Google Patents

Formulations for coated microprojections containing non-volatile counterions Download PDF

Info

Publication number
WO2005004842A3
WO2005004842A3 PCT/US2004/021004 US2004021004W WO2005004842A3 WO 2005004842 A3 WO2005004842 A3 WO 2005004842A3 US 2004021004 W US2004021004 W US 2004021004W WO 2005004842 A3 WO2005004842 A3 WO 2005004842A3
Authority
WO
WIPO (PCT)
Prior art keywords
formulations
containing non
coated microprojections
counterions
volatile counterions
Prior art date
Application number
PCT/US2004/021004
Other languages
French (fr)
Other versions
WO2005004842A2 (en
Inventor
Mahmoud Ameri
Weiqi Lin
Michel J N Cormier
Yuh-Fun Maa
Original Assignee
Alza Corp
Mahmoud Ameri
Weiqi Lin
Michel J N Cormier
Yuh-Fun Maa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp, Mahmoud Ameri, Weiqi Lin, Michel J N Cormier, Yuh-Fun Maa filed Critical Alza Corp
Priority to CN2004800243347A priority Critical patent/CN1842320B/en
Priority to ES04756422.4T priority patent/ES2437565T3/en
Priority to CA002530531A priority patent/CA2530531A1/en
Priority to JP2006518731A priority patent/JP5456234B2/en
Priority to EP04756422.4A priority patent/EP1638523B8/en
Priority to BRPI0412029-9A priority patent/BRPI0412029A/en
Priority to MXPA06000281A priority patent/MXPA06000281A/en
Priority to AU2004255218A priority patent/AU2004255218A1/en
Publication of WO2005004842A2 publication Critical patent/WO2005004842A2/en
Publication of WO2005004842A3 publication Critical patent/WO2005004842A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

The invention provides for a formulation for coating one or more microprojections which reduces or minimizes the loss of counterions from the coating in order to achieve a pH-stabilized formulation.
PCT/US2004/021004 2003-06-30 2004-06-29 Formulations for coated microprojections containing non-volatile counterions WO2005004842A2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
CN2004800243347A CN1842320B (en) 2003-06-30 2004-06-29 Formulations for coated microprojections containing non-volatile counterions
ES04756422.4T ES2437565T3 (en) 2003-06-30 2004-06-29 Formulations for coated microprojections containing non-volatile counterions
CA002530531A CA2530531A1 (en) 2003-06-30 2004-06-29 Formulations for coated microprojections containing non-volatile counterions
JP2006518731A JP5456234B2 (en) 2003-06-30 2004-06-29 Formulations for coated microprojections containing non-volatile counterions
EP04756422.4A EP1638523B8 (en) 2003-06-30 2004-06-29 Formulations for coated microprojections containing non-volatile counterions
BRPI0412029-9A BRPI0412029A (en) 2003-06-30 2004-06-29 formulations for coated microprojections containing nonvolatile counterions
MXPA06000281A MXPA06000281A (en) 2003-06-30 2004-06-29 Formulations for coated microprojections containing non-volatile counterions.
AU2004255218A AU2004255218A1 (en) 2003-06-30 2004-06-29 Formulations for coated microprojections containing non-volatile counterions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48402003P 2003-06-30 2003-06-30
US60/484,020 2003-06-30

Publications (2)

Publication Number Publication Date
WO2005004842A2 WO2005004842A2 (en) 2005-01-20
WO2005004842A3 true WO2005004842A3 (en) 2005-04-21

Family

ID=34062010

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/021004 WO2005004842A2 (en) 2003-06-30 2004-06-29 Formulations for coated microprojections containing non-volatile counterions

Country Status (13)

Country Link
US (2) US7579013B2 (en)
EP (1) EP1638523B8 (en)
JP (1) JP5456234B2 (en)
KR (1) KR20060038407A (en)
CN (1) CN1842320B (en)
AR (1) AR044964A1 (en)
AU (1) AU2004255218A1 (en)
BR (1) BRPI0412029A (en)
CA (1) CA2530531A1 (en)
ES (1) ES2437565T3 (en)
MX (1) MXPA06000281A (en)
TW (1) TW200518771A (en)
WO (1) WO2005004842A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8975082B2 (en) 2008-05-13 2015-03-10 University Of Kansas Metal abstraction peptide (MAP) tag and associated methods
US9187735B2 (en) 2012-06-01 2015-11-17 University Of Kansas Metal abstraction peptide with superoxide dismutase activity

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6918901B1 (en) * 1997-12-10 2005-07-19 Felix Theeuwes Device and method for enhancing transdermal agent flux
US7419481B2 (en) * 2000-10-13 2008-09-02 Alza Corporation Apparatus and method for piercing skin with microprotrusions
KR20030068136A (en) * 2000-10-13 2003-08-19 알자 코포레이션 Apparatus and method for piercing skin with microprotrusions
ES2317940T3 (en) * 2000-10-13 2009-05-01 Alza Corporation RETAINING DEVICE FOR A MICROSALIENT ELEMENT FOR IMPACT APPLICATOR.
CN1239212C (en) * 2000-10-26 2006-02-01 阿尔扎公司 Device for percutaneous transdermal delivery having coated micro-protrusions
US6855372B2 (en) * 2001-03-16 2005-02-15 Alza Corporation Method and apparatus for coating skin piercing microprojections
US20020193729A1 (en) * 2001-04-20 2002-12-19 Cormier Michel J.N. Microprojection array immunization patch and method
BRPI0412029A (en) * 2003-06-30 2006-09-05 Alza Corp formulations for coated microprojections containing nonvolatile counterions
PT1638468E (en) * 2003-06-30 2007-10-10 Alza Corp Method for coating skin piercing microprojections
US20050123507A1 (en) * 2003-06-30 2005-06-09 Mahmoud Ameri Formulations for coated microprojections having controlled solubility
TW200513280A (en) * 2003-07-02 2005-04-16 Alza Corp Microprojection array immunization patch and method
BRPI0413360A (en) * 2003-08-04 2006-10-10 Alza Corp method and device for increasing the flow of transdermal agents
US8524272B2 (en) 2003-08-15 2013-09-03 Mylan Technologies, Inc. Transdermal patch incorporating active agent migration barrier layer
AU2004268616B2 (en) 2003-08-25 2010-10-07 3M Innovative Properties Company Delivery of immune response modifier compounds
JP2007519613A (en) * 2003-10-23 2007-07-19 アルザ・コーポレーシヨン Stabilized DNA composition for coating microprojections
AU2004285484A1 (en) * 2003-10-24 2005-05-12 Alza Corporation Pretreatment method and system for enhancing transdermal drug delivery
WO2005044139A2 (en) * 2003-10-28 2005-05-19 Alza Corporation Method and apparatus for reducing the incidence of tobacco use
CN100571643C (en) 2003-10-31 2009-12-23 阿尔扎公司 The self-driven applicator that is used for microprotrusion array
CN100548228C (en) * 2003-11-13 2009-10-14 阿尔扎公司 The compositions and the device that are used for transdermal delivery
EP1735469A2 (en) * 2004-04-13 2006-12-27 ALZA Corporation Apparatus and method for transdermal delivery of multiple vaccines
CA2566032A1 (en) * 2004-05-13 2005-12-01 Alza Corporation Apparatus and method for transdermal delivery of parathyroid hormone agents
WO2006020841A2 (en) * 2004-08-11 2006-02-23 Alza Corporation Apparatus and method for transdermal delivery of natriuretic peptides
EP1838290A2 (en) * 2005-01-21 2007-10-03 Alza Corporation Therapeutic peptide formulations for coating microneedles with improved stability containing at least one counterion
EP1843783B1 (en) * 2005-01-25 2012-05-30 MicroCHIPS, Inc. Control of drug release by transient modification of local microenvironments
EP1853231A2 (en) * 2005-02-16 2007-11-14 Alza Corporation Apparatus and method for transdermal delivery of erythropoetin-based agents
CN101189030A (en) * 2005-06-02 2008-05-28 阿尔扎公司 Method for terminal sterilization of transdermal delivery devices
JP5438872B2 (en) * 2005-06-02 2014-03-12 アルザ コーポレイション Final sterilization method for transdermal delivery devices
EP1924364A1 (en) * 2005-09-12 2008-05-28 Alza Corporation Coatable transdermal delivery microprojection assembly
CA2629193C (en) * 2005-11-18 2016-03-29 3M Innovative Properties Company Coatable compositions, coatings derived therefrom and microarrays having such coatings
US8554317B2 (en) * 2005-11-30 2013-10-08 3M Innovative Properties Company Microneedle arrays and methods of use thereof
CA2635251A1 (en) * 2005-12-28 2007-07-26 Alza Corporation Stable therapeutic formulations
US20080039775A1 (en) * 2006-03-15 2008-02-14 Alza Corporation Apparatus and Method for Transdermal Delivery of Parathyroid Hormone Agents to Prevent or Treat Osteopenia
US20070293816A1 (en) * 2006-04-25 2007-12-20 Alza Corporation Microprojection Array Application with Grouped Microprojections for High Drug Loading
US20070299388A1 (en) * 2006-04-25 2007-12-27 Alza Corporation Microprojection array application with multilayered microprojection member for high drug loading
US7771542B1 (en) 2006-05-30 2010-08-10 Stone Chemical Company Compositions and methods for removing lead from metal surfaces
EP2568806B1 (en) 2010-05-12 2016-05-11 Radius Health, Inc. Therapeutic regimens
WO2011150144A2 (en) 2010-05-28 2011-12-01 3M Innovative Properties Company Aqueous formulations for coating microneedle arrays
JP5965909B2 (en) 2010-09-28 2016-08-10 ラジウス ヘルス，インコーポレイテッド Selective androgen receptor modulator
JP2013544600A (en) * 2010-11-23 2013-12-19 プレサージュ バイオサイエンシズ，インコーポレイテッド Therapeutic methods and compositions for solid delivery
CN102090904B (en) * 2011-02-17 2013-04-03 中国中医科学院中医临床基础医学研究所 Rapid allergic skin test detector of Chinese medicine injection
US20120222979A1 (en) 2011-03-04 2012-09-06 Elwha LLC, a limited liability company of the State of Delaware Glassy compositions
NL2007382C2 (en) * 2011-09-09 2013-03-12 Univ Leiden Method to coat an active agent to a surface.
EP2771043A4 (en) 2011-10-28 2015-04-29 Presage Biosciences Inc Methods for drug delivery
CA2857502C (en) 2011-11-30 2019-08-13 3M Innovative Properties Company Microneedle device including a peptide therapeutic agent and an amino acid and methods of making and using the same
US10980865B2 (en) 2012-08-10 2021-04-20 Aquavit Pharmaceuticals, Inc. Direct application system and method for the delivery of bioactive compositions and formulations
SG11201506326YA (en) 2013-02-13 2015-09-29 Hisamitsu Pharmaceutical Co Microneedle coating composition and microneedle device
ES2692722T3 (en) 2013-02-13 2018-12-04 Hisamitsu Pharmaceutical Co., Inc. Microneedle coating composition and microneedle device
US9782344B2 (en) * 2013-08-22 2017-10-10 Zp Opco, Inc. Stable glucagon peptide formulations
ES2708996T3 (en) * 2013-08-22 2019-04-12 Zp Opco Inc Stable formulations of glucagon peptide
WO2016122915A1 (en) 2015-01-27 2016-08-04 3M Innovative Properties Company Alum-containing coating formulations for microneedle vaccine patches
US9750785B2 (en) 2015-01-30 2017-09-05 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9687526B2 (en) 2015-01-30 2017-06-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9375478B1 (en) 2015-01-30 2016-06-28 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744209B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9937223B2 (en) 2015-01-30 2018-04-10 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
CN113750091A (en) 2015-04-29 2021-12-07 雷迪厄斯制药公司 Methods for treating cancer
EP4049651A1 (en) 2015-10-09 2022-08-31 Kindeva Drug Delivery L.P. Zinc compositions for coated microneedle arrays
US9918932B2 (en) 2016-02-19 2018-03-20 Zosano Pharma Corporation Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines
WO2017184355A1 (en) * 2016-04-18 2017-10-26 Radius Health, Inc. Formulations of abaloparatide, transdermal patches thereof, and uses thereof
NZ749192A (en) 2016-06-22 2022-07-29 Ellipses Pharma Ltd Ar+ breast cancer treatment methods
AR109621A1 (en) * 2016-10-24 2018-12-26 Janssen Pharmaceuticals Inc FORMULATIONS OF VACCINES AGAINST GLUCOCONJUGADOS OF EXPEC
KR102322802B1 (en) 2017-01-05 2021-11-04 래디어스 파마슈티컬스, 인코포레이티드 Polymorphic form of RAD1901-2HCL
US11660264B2 (en) 2017-08-23 2023-05-30 Emergex USA Corporation Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches
SG10201800072YA (en) * 2018-01-03 2019-08-27 Micropoint Tech Pte Ltd Microneedle Patches Comprising Corticosteroid
US11660265B2 (en) 2018-06-28 2023-05-30 Emergex USA Corporation Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches
CN108721598B (en) * 2018-07-03 2020-06-05 北京市新里程医药科技有限公司 Preparation method of oxytocin raw material, pharmaceutical composition and preparation thereof
WO2020010216A1 (en) 2018-07-04 2020-01-09 Radius Pharmaceuticals, Inc. Polymorphic forms of rad 1901-2hcl

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999038492A1 (en) * 1998-01-30 1999-08-05 Novartis Consumer Health S.A. Nasal solutions
WO2000021533A1 (en) * 1998-10-15 2000-04-20 Astrazeneca Ab A dried or frozen pharmaceutical preparation containing a class iii antiarrhythmic compound
WO2000037079A1 (en) * 1998-12-22 2000-06-29 Bausch & Lomb Incorporated Ophtalmic compositions comprising pheniramine and a demulcent such as pvp
WO2000043405A1 (en) * 1999-01-20 2000-07-27 Isis Innovation Limited Bis-terpyridine-platinum(ii) complexes
WO2001041863A1 (en) * 1999-12-10 2001-06-14 Alza Corporation Device and method for enhancing microprotrusion skin piercing
EP1110455A1 (en) * 1998-09-03 2001-06-27 Kurita Water Industries Ltd. Antibacterial compositions
WO2002000200A1 (en) * 2000-06-29 2002-01-03 Glaxo Group Limited Novel process for preparing crystalline particles
US20020128599A1 (en) * 2000-10-26 2002-09-12 Cormier Michel J.N. Transdermal drug delivery devices having coated microprotrusions
WO2002085447A2 (en) * 2001-04-20 2002-10-31 Alza Corporation Microprojection array having a beneficial agent containing coating
EP1283043A1 (en) * 2000-05-17 2003-02-12 Senju Pharmaceutical Co., Ltd. Ophthalmic solution
WO2003051284A2 (en) * 2001-10-29 2003-06-26 Becton, Dickinson And Company Method and device for the delivery of a substance
WO2005002453A1 (en) * 2003-07-02 2005-01-13 Alza Corporation Microprojection array immunization patch and method
WO2005004729A1 (en) * 2003-06-30 2005-01-20 Alza Corporation Method for coating skin piercing microprojections

Family Cites Families (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE25637E (en) 1964-09-08 Means for vaccinating
US3123212A (en) 1964-03-03 Multiple disposable intracutaneous injector package
GB179994A (en) 1921-02-02 1922-05-02 Achilee Macchioni Throttling of the exhaust in a two-stroke cycle internal combustion motor applied to a locomotive for the purpose of increasing the power of the said motor
US2619962A (en) 1948-02-19 1952-12-02 Res Foundation Vaccination appliance
US2893392A (en) 1958-01-08 1959-07-07 American Cyanamid Co Article of manufacture for intracutaneous injections
US3072122A (en) 1959-01-15 1963-01-08 Rosenthal Sol Roy Package for transcutaneous injection
US3136314A (en) 1960-08-01 1964-06-09 Kravitz Harvey Vaccinating devices
US3221739A (en) 1962-03-26 1965-12-07 Rosenthal Sol Roy Injection device
US3221740A (en) 1962-08-31 1965-12-07 Rosenthal Sol Roy Injection device
US3964482A (en) 1971-05-17 1976-06-22 Alza Corporation Drug delivery device
US3678150A (en) 1971-07-27 1972-07-18 American Cyanamid Co Process for improving the stability of ppd, qt and histoplasmin on tine applicators
BE795384A (en) 1972-02-14 1973-08-13 Ici Ltd DRESSINGS
OA05448A (en) 1975-10-16 1981-03-31 Manufrance Manufacture Francai Multi-penetrating vaccine device.
FR2474856A1 (en) 1980-01-31 1981-08-07 Merieux Inst SCARIFIER DEVICE
SE8501990D0 (en) 1985-04-24 1985-04-24 Pharmacia Ab BELEGGNINGSFORFARANDE
KR970008118B1 (en) * 1987-07-09 1997-05-21 엘테에스 로오만 테라피-지스테메 게엠베하 운트 콤파니 카게 Transdermal therapeutic system
US5051132A (en) * 1989-06-15 1991-09-24 Nippon Kayaku Kabushiki Kaisha Lyophilized preparation of 6-(3-dimethylaminopropionyl)forskolin
CA2016900A1 (en) 1989-07-06 1991-01-06 Ronald J. Filipski Tines structure in clinical applicator
EP0429842B1 (en) 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Device for the transdermal administration of protein or peptide drug
JPH04134033A (en) * 1990-01-19 1992-05-07 Nippon Kayaku Co Ltd Lyophilized preparation of ethoposide-2-dimethylamino compound
US5279544A (en) 1990-12-13 1994-01-18 Sil Medics Ltd. Transdermal or interdermal drug delivery devices
DE4242919A1 (en) * 1992-12-18 1994-06-23 Boehringer Mannheim Gmbh Process for the preparation of storage-stable aqueous pharmaceutical preparations of G-CSF
DE4341444C2 (en) * 1993-12-04 1996-03-14 Lohmann Therapie Syst Lts Active substance-containing plaster and process for its production
US5496801A (en) * 1993-12-23 1996-03-05 Allelix Biopharmaceuticals Inc. Parathyroid hormone formulation
US5487726A (en) 1994-06-16 1996-01-30 Ryder International Corporation Vaccine applicator system
MX9701394A (en) 1994-08-04 1998-03-31 Quadrant Holdings Cambridge Solid delivery systems for controlled release of molecules incorporated therein and methods of making same.
US6290991B1 (en) * 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
WO1996010630A1 (en) 1994-09-30 1996-04-11 Rutgers, The State University Direct introduction of foreign materials into cells
AU4256496A (en) 1994-12-09 1996-06-26 Novartis Ag Transdermal system
US5866536A (en) * 1995-03-31 1999-02-02 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
AU5740496A (en) 1995-05-22 1996-12-11 General Hospital Corporation, The Micromechanical device and method for enhancing delivery of compounds through the skin
WO1996037256A1 (en) * 1995-05-22 1996-11-28 Silicon Microdevices, Inc. Micromechanical patch for enhancing the delivery of compounds through the skin
DE19525607A1 (en) 1995-07-14 1997-01-16 Boehringer Ingelheim Kg Transcorneal drug delivery system
EP0914178B1 (en) 1996-06-18 2003-03-12 Alza Corporation Device for enhancing transdermal agent delivery or sampling
DK0921840T3 (en) 1996-07-03 2003-09-22 Altea Therapeutics Corp Multiple mechanical microperforation of skin or mucosa
US5743960A (en) 1996-07-26 1998-04-28 Bio-Dot, Inc. Precision metered solenoid valve dispenser
US5916524A (en) 1997-07-23 1999-06-29 Bio-Dot, Inc. Dispensing apparatus having improved dynamic range
US5741554A (en) 1996-07-26 1998-04-21 Bio Dot, Inc. Method of dispensing a liquid reagent
US5738728A (en) 1996-07-26 1998-04-14 Bio Dot, Inc. Precision metered aerosol dispensing apparatus
CA2265906C (en) * 1996-09-17 2003-11-11 Deka Products Limited Partnership System for delivery of drugs by transport
WO1998028037A1 (en) 1996-12-20 1998-07-02 Alza Corporation Device and method for enhancing transdermal agent flux
DE19654391A1 (en) 1996-12-27 1998-07-02 Basf Ag Catalyst for the selective production of propylene from propane
WO1998029298A1 (en) 1996-12-31 1998-07-09 Shell Internationale Research Maatschappij B.V. Spar platform with vertical slots
US6918901B1 (en) * 1997-12-10 2005-07-19 Felix Theeuwes Device and method for enhancing transdermal agent flux
EP1037687B8 (en) * 1997-12-11 2008-10-22 Alza Corporation Device for enhancing transdermal agent flux
JP2001525232A (en) 1997-12-11 2001-12-11 アルザ・コーポレーション Device for enhancing transdermal substance flow
AU739616B2 (en) 1997-12-11 2001-10-18 Alza Corporation Device for enhancing transdermal agent flux
US6091975A (en) 1998-04-01 2000-07-18 Alza Corporation Minimally invasive detecting device
WO1999064580A1 (en) 1998-06-10 1999-12-16 Georgia Tech Research Corporation Microneedle devices and methods of manufacture and use thereof
US6532386B2 (en) 1998-08-31 2003-03-11 Johnson & Johnson Consumer Companies, Inc. Electrotransort device comprising blades
US6884427B1 (en) * 1999-02-08 2005-04-26 Aderans Research Institute, Inc. Filamentary means for introducing agents into tissue of a living host
US6743211B1 (en) * 1999-11-23 2004-06-01 Georgia Tech Research Corporation Devices and methods for enhanced microneedle penetration of biological barriers
US6379324B1 (en) * 1999-06-09 2002-04-30 The Procter & Gamble Company Intracutaneous microneedle array apparatus
US6256533B1 (en) * 1999-06-09 2001-07-03 The Procter & Gamble Company Apparatus and method for using an intracutaneous microneedle array
GB9916316D0 (en) * 1999-07-12 1999-09-15 Quadrant Holdings Cambridge Dry powder compositions
US6623457B1 (en) * 1999-09-22 2003-09-23 Becton, Dickinson And Company Method and apparatus for the transdermal administration of a substance
US6835184B1 (en) * 1999-09-24 2004-12-28 Becton, Dickinson And Company Method and device for abrading skin
US20020095134A1 (en) * 1999-10-14 2002-07-18 Pettis Ronald J. Method for altering drug pharmacokinetics based on medical delivery platform
CH694730A5 (en) * 2000-02-09 2005-06-30 Sumitomo Chemical Co A process for producing optically active hemiester.
US20020061838A1 (en) * 2000-05-17 2002-05-23 Barton Holmquist Peptide pharmaceutical formulations
US6565532B1 (en) 2000-07-12 2003-05-20 The Procter & Gamble Company Microneedle apparatus used for marking skin and for dispensing semi-permanent subcutaneous makeup
US6537242B1 (en) * 2000-06-06 2003-03-25 Becton, Dickinson And Company Method and apparatus for enhancing penetration of a member for the intradermal sampling or administration of a substance
US6589202B1 (en) * 2000-06-29 2003-07-08 Becton Dickinson And Company Method and apparatus for transdermally sampling or administering a substance to a patient
US20050008683A1 (en) * 2000-06-29 2005-01-13 Becton Dickinson And Company Method for delivering interferons to the intradermal compartment
US6440096B1 (en) * 2000-07-14 2002-08-27 Becton, Dickinson And Co. Microdevice and method of manufacturing a microdevice
GB0017999D0 (en) * 2000-07-21 2000-09-13 Smithkline Beecham Biolog Novel device
DE60129585T2 (en) * 2000-09-08 2008-04-17 Alza Corp., Mountain View TRANSDERMALE DEVICE
ES2317940T3 (en) * 2000-10-13 2009-05-01 Alza Corporation RETAINING DEVICE FOR A MICROSALIENT ELEMENT FOR IMPACT APPLICATOR.
KR20030068136A (en) * 2000-10-13 2003-08-19 알자 코포레이션 Apparatus and method for piercing skin with microprotrusions
CA2425537C (en) * 2000-10-13 2009-09-08 Alza Corporation Microblade array impact applicator
WO2002064193A2 (en) * 2000-12-14 2002-08-22 Georgia Tech Research Corporation Microneedle devices and production thereof
US6855372B2 (en) 2001-03-16 2005-02-15 Alza Corporation Method and apparatus for coating skin piercing microprojections
US20020193729A1 (en) * 2001-04-20 2002-12-19 Cormier Michel J.N. Microprojection array immunization patch and method
US6881203B2 (en) * 2001-09-05 2005-04-19 3M Innovative Properties Company Microneedle arrays and methods of manufacturing the same
EP1469903A2 (en) * 2001-09-28 2004-10-27 BioValve Technologies, Inc. Microneedle with membrane
US6689100B2 (en) * 2001-10-05 2004-02-10 Becton, Dickinson And Company Microdevice and method of delivering or withdrawing a substance through the skin of an animal
US20030199810A1 (en) * 2001-11-30 2003-10-23 Trautman Joseph Creagan Methods and apparatuses for forming microprojection arrays
ES2297056T3 (en) * 2001-12-20 2008-05-01 Alza Corporation MICRO-PROJECTIONS FOR SKIN PERFORATION THAT HAVE CONTROL OF THE DEPTH OF DRILLING.
US7015262B2 (en) 2002-05-01 2006-03-21 Lifescan, Inc. Hydrophilic coatings for medical implements
KR20050054483A (en) 2002-06-28 2005-06-10 알자 코포레이션 Transdermal drug delivery devices having coated microprotrusions
AR042815A1 (en) * 2002-12-26 2005-07-06 Alza Corp ACTIVE AGENT SUPPLY DEVICE THAT HAS COMPOUND MEMBERS
US20050123507A1 (en) * 2003-06-30 2005-06-09 Mahmoud Ameri Formulations for coated microprojections having controlled solubility
BRPI0412029A (en) * 2003-06-30 2006-09-05 Alza Corp formulations for coated microprojections containing nonvolatile counterions
CN100571643C (en) * 2003-10-31 2009-12-23 阿尔扎公司 The self-driven applicator that is used for microprotrusion array
CN100548228C (en) * 2003-11-13 2009-10-14 阿尔扎公司 The compositions and the device that are used for transdermal delivery
EP1838290A2 (en) * 2005-01-21 2007-10-03 Alza Corporation Therapeutic peptide formulations for coating microneedles with improved stability containing at least one counterion
US9960402B2 (en) 2016-09-07 2018-05-01 Thunder Power New Energy Vehicle Development Company Limited Process of manufacturing a battery system assembly using the battery system assembly press

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999038492A1 (en) * 1998-01-30 1999-08-05 Novartis Consumer Health S.A. Nasal solutions
EP1110455A1 (en) * 1998-09-03 2001-06-27 Kurita Water Industries Ltd. Antibacterial compositions
WO2000021533A1 (en) * 1998-10-15 2000-04-20 Astrazeneca Ab A dried or frozen pharmaceutical preparation containing a class iii antiarrhythmic compound
WO2000037079A1 (en) * 1998-12-22 2000-06-29 Bausch & Lomb Incorporated Ophtalmic compositions comprising pheniramine and a demulcent such as pvp
WO2000043405A1 (en) * 1999-01-20 2000-07-27 Isis Innovation Limited Bis-terpyridine-platinum(ii) complexes
WO2001041863A1 (en) * 1999-12-10 2001-06-14 Alza Corporation Device and method for enhancing microprotrusion skin piercing
EP1283043A1 (en) * 2000-05-17 2003-02-12 Senju Pharmaceutical Co., Ltd. Ophthalmic solution
WO2002000200A1 (en) * 2000-06-29 2002-01-03 Glaxo Group Limited Novel process for preparing crystalline particles
WO2002094368A1 (en) * 2000-10-26 2002-11-28 Alza Corporation Transdermal drug delivery devices having coated microprotrusions
US20020128599A1 (en) * 2000-10-26 2002-09-12 Cormier Michel J.N. Transdermal drug delivery devices having coated microprotrusions
WO2002085447A2 (en) * 2001-04-20 2002-10-31 Alza Corporation Microprojection array having a beneficial agent containing coating
WO2003051284A2 (en) * 2001-10-29 2003-06-26 Becton, Dickinson And Company Method and device for the delivery of a substance
WO2005004729A1 (en) * 2003-06-30 2005-01-20 Alza Corporation Method for coating skin piercing microprojections
WO2005002453A1 (en) * 2003-07-02 2005-01-13 Alza Corporation Microprojection array immunization patch and method

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8975082B2 (en) 2008-05-13 2015-03-10 University Of Kansas Metal abstraction peptide (MAP) tag and associated methods
US9096652B2 (en) 2008-05-13 2015-08-04 University Of Kansas Metal abstraction peptide (MAP) tag and associated methods
US9187735B2 (en) 2012-06-01 2015-11-17 University Of Kansas Metal abstraction peptide with superoxide dismutase activity

Also Published As

Publication number Publication date
JP2007527392A (en) 2007-09-27
AR044964A1 (en) 2005-10-12
ES2437565T3 (en) 2014-01-13
MXPA06000281A (en) 2006-07-03
CN1842320A (en) 2006-10-04
CA2530531A1 (en) 2005-01-20
EP1638523B1 (en) 2013-10-30
US7579013B2 (en) 2009-08-25
BRPI0412029A (en) 2006-09-05
EP1638523A2 (en) 2006-03-29
EP1638523B8 (en) 2013-12-25
JP5456234B2 (en) 2014-03-26
US8920817B2 (en) 2014-12-30
KR20060038407A (en) 2006-05-03
AU2004255218A1 (en) 2005-01-20
WO2005004842A2 (en) 2005-01-20
TW200518771A (en) 2005-06-16
US20040265354A1 (en) 2004-12-30
US20100221305A1 (en) 2010-09-02
CN1842320B (en) 2013-06-19

Similar Documents

Publication Publication Date Title
WO2005004842A3 (en) Formulations for coated microprojections containing non-volatile counterions
MXPA03006774A (en) Coating compositions for modifying surfaces.
DK1499667T3 (en) Coating composition for multiple hydrophilic applications
WO2006116348A3 (en) Compositions for medical devices containing agent combinations in controlled volumes
EP1601732A4 (en) Curable coating compositions
AU2003265456A1 (en) Guidewire having different coatings
TW200635620A (en) Formulations for coated microprojections having controlled solubility
PL1498461T3 (en) Solvent containing coating compositions
AU2003254861A1 (en) Coating composition
AU2003302035A1 (en) Formulations used for the treatment of substrate surfaces
ITRM20040015A1 (en) PROCEDURE FOR THE COMPOSITION OF A NANOCOMPOSIT COATING.
AU2001280577A1 (en) Curable coating compositions
AU2002352061A1 (en) Polyorganosiloxane compositions which can be painted or coated over
AU2003221172A1 (en) Water-based coating composition
AU2003242760A1 (en) Coating compositions
AU2002325893A1 (en) Unsaturated powder coating compositions
AU2003273819A1 (en) Coating agent
GB0308895D0 (en) Coating compositions
AU2003297440A1 (en) Coating composition
AU2003901311A0 (en) Coating compositions
AU2003229500A1 (en) Water-based coating fluid
AU2002365368A1 (en) Water-based adhesive compositions
WO2008058885A3 (en) Radiation-hardenable coating masses
AU2002327498A1 (en) Stabilized coating compositions
AUPS033402A0 (en) Coating compositions

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200480024334.7

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004255218

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2530531

Country of ref document: CA

Ref document number: 544354

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2004756422

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2006518731

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 1020057025323

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: PA/a/2006/000281

Country of ref document: MX

ENP Entry into the national phase

Ref document number: 2004255218

Country of ref document: AU

Date of ref document: 20040629

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004255218

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2004756422

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1020057025323

Country of ref document: KR

ENP Entry into the national phase

Ref document number: PI0412029

Country of ref document: BR